Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Tenaya Therapeutics, Inc. (TNYA) had Free Cash Flow per Share of $-0.24 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-23.28M |
|
-- |
|
-- |
|
$24.08M |
|
$-24.08M |
|
$0.80M |
|
$-23.28M |
|
$-23.28M |
|
$-23.28M |
|
$-23.28M |
|
$-23.28M |
|
$-23.28M |
|
$-24.08M |
|
$-21.73M |
|
162.79M |
|
162.79M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$75.88M |
|
$31.29M |
|
$46.28M |
|
$122.15M |
|
$12.65M |
|
-- |
|
$9.67M |
|
$22.32M |
|
$99.83M |
|
$99.83M |
|
$99.83M |
|
162.98M |
|
| Cash Flow Statement Financials | |
$-38.73M |
|
$47.29M |
|
$49.78M |
|
$4.74M |
|
$63.09M |
|
$58.35M |
|
$7.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-39.25M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-23.32% |
|
-23.32% |
|
-19.06% |
|
-23.32% |
|
$0.61 |
|
|
Free Cash Flow per Share |
$-0.24 |
$-0.24 |
|